Daniel Amoako is a researcher at the Department of Pathobiology at the University of Guelph, Canada, and the College of Health Sciences at the University of KwaZulu-Natal, South Africa. He has a longstanding interest in microbial bioinformatics; his research applies genome sequencing and data analytics to better understand emerging pathogens and their mechanisms of resistance and virulence. He has been involved in many large-scale bacterial whole-genome sequencing projects and actively translates microbial genomic data into genomic epidemiology for the benefit of the public, private, food, animal, and environmental health sectors (One-Health Context) globally. He has been working with several organizations such as the Africa Pathogen Genomics Initiative (Africa PGI)/Africa CDC, Centre for Respiratory Diseases and Meningitis at the National Institute for Communicable Diseases, SEQAFRICA-Fleming Fund, Network for Genomic Surveillance in South Africa (NGS-SA), COG-Train/COVID-19 Genomics UK Consortium, Southern African Training & Research Network for Genomic Surveillance of Antimicrobial Resistance (SAGESA-SA), Mobilome Ontology (MOBIO) working group, RSV genotyping consortium-ECDC-WHO, CARD-AMR/Canada etc., spearheading training and implementation of bioinformatics worldwide. To date, Amoako has authored/co-authored over 120 publications in leading peer-reviewed journals, with over 8000 citations and an H-index of 38. Additionally, he has successfully supervised/co-supervised 15 PhD/MSc students, contributing to the advancement of scientific knowledge in his field.
ORCID: https://orcid.org/0000-0003-3551-3458
Google Scholar: https://scholar.google.com/citations?user=MCZ6Z-QAAAAJ&hl=en
LinkedIn: https://www.linkedin.com/in/daniel-gyamfi-amoako-phd-72684659/
Website: https://www.researchgate.net/profile/Daniel-Amoako-2?ev=hdr_xprf